Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mead Johnson Likely To Draw Suitors Following BMS Split

This article was originally published in The Tan Sheet

Executive Summary

Mead Johnson's impending split-off from Bristol-Myers Squibb, announced Nov. 16, makes the rapidly growing nutritional company an appealing acquisition target for the back half of 2010, analysts predict

You may also be interested in...



Danone Shakes Up Elderly Care Market With Offer For Medical Nutrition USA

Danone's $62.3 million bid for Medical Nutrition USA will boost the French firm's U.S. nutritional product business, but securities litigators fishing for clients say the deal may shortchange MN shareholders

Danone Shakes Up Elderly Care Market With Offer For Medical Nutrition USA

Danone's $62.3 million bid for Medical Nutrition USA will boost the French firm's U.S. nutritional product business, but securities litigators fishing for clients say the deal may shortchange MN shareholders

Danone Shakes Up Elderly Care Market With Offer For Medical Nutrition USA

Danone's $62.3 million bid for Medical Nutrition USA will boost the French firm's U.S. nutritional product business, but securities litigators fishing for clients say the deal may shortchange MN shareholders

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel